4 completed, 1 recruiting. 2 Phase 2, 2 Phase 3, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Recruiting 1 |
| Phase 3 | 2 | Completed 2 |
| Phase 1 | 1 | Completed 1 |
Follow Pramipexole Immediate Release: new trials by email Literature Review of Pramipexole Immediate Release trials Research Report on Pramipexole Immediate Release
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Stratified Pharmacological Approaches for Regulating Circuit-Level Effects Pramipexole Immediate Release - Depression - Major Depressive Disorder | Phase 2 | Recruiting | Stanford University | 60 | 2026-01-23 | 2026-05-15 |
| Multiple Dose Bioequivalence Study of Pramipexole Extended Release in Chinese Healthy Male Volunteers pramipexole extended release, pramipexole immediate release - Healthy | Phase 1 | Completed | Boehringer Ingelheim | 24 | 2010-12-01 | 2014-06-27 |
| A 12-week Study of Pramipexole Extended Release (ER) in Patients With Parkinson's Disease (PD), Followed by a 52-week Long-term Treatment Period Pramipexole Immediate Release, Pramipexole Extended Release - Parkinson Disease | Phase 2 / Phase 3 | Completed | Boehringer Ingelheim | 112 | 2007-11-01 | 2014-07-31 |
| Overnight Switch Trial From Pramipexole IR to Pramipexole ER in Patients With Early Parkinson Disease Pramipexole Extended Release, Pramipexole Immediate Release - Parkinson Disease | Phase 3 | Completed | Boehringer Ingelheim | 156 | 2007-10-01 | 2014-05-16 |
| Non-motor Symptoms (Depressive Symptoms) of Parkinson's Disease and Their Course Under Pramipexole Treatment Pramipexole immediate release - Parkinson Disease | Completed | Boehringer Ingelheim | 286 | 2014-05-20 |
Boehringer Ingelheim (4) · Stanford University (1)
Austria (1) · China (1) · France (1) · Germany (1) · Japan (1) · Netherlands (1) · United States (1)
U01MH136062 (1)